Affibody-mediated PET imaging of HER3 expression in malignant tumours
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Affibody-mediated PET imaging of HER3 expression in malignant tumours
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-19
DOI
10.1038/srep15226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The promise of anti-ErbB3 monoclonals as new cancer therapeutics
- (2015) Luigi Aurisicchio et al. Oncotarget
- The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells
- (2015) Hisato Kawakami et al. Oncotarget
- A role for the pseudokinase HER3 in the acquired resistance against EGFR- and HER2-directed targeted therapy
- (2014) Jeroen Claus et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Molecular Pathways: HER3 Targeted Therapy
- (2014) K. Gala et al. CLINICAL CANCER RESEARCH
- Imaging of HER3-expressing xenografts in mice using a 99mTc(CO)3-HEHEHE-ZHER3:08699 affibody molecule
- (2014) Anna Orlova et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Imaging of Platelet-Derived Growth Factor Receptor Expression in Glioblastoma Xenografts Using Affibody Molecule 111In-DOTA-Z09591
- (2014) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule
- (2014) J. Sorensen et al. JOURNAL OF NUCLEAR MEDICINE
- ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody89Zr-RG7116
- (2014) Anton GT Terwisscha van Scheltinga et al. mAbs
- Targeting of erbB3 receptor to overcome resistance in cancer treatment
- (2014) Jian Ma et al. Molecular Cancer
- Pharmacological targeting of the pseudokinase Her3
- (2014) Ting Xie et al. Nature Chemical Biology
- HER3, serious partner in crime
- (2014) Arjan Kol et al. PHARMACOLOGY & THERAPEUTICS
- In Vivo and In Vitro Studies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors
- (2013) Mohamed Altai et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
- (2013) Magdalena Malm et al. PLoS One
- Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts
- (2013) Joanna Strand et al. PLoS One
- Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging
- (2012) Alain P. Pecking et al. CLINICAL & EXPERIMENTAL METASTASIS
- [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours
- (2012) Anna Orlova et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab-Heregulin Bispecific Radioimmunoconjugates
- (2012) E. J. Razumienko et al. JOURNAL OF NUCLEAR MEDICINE
- Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition
- (2012) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Non-immunoglobulin based protein scaffolds
- (2011) John Löfblom et al. CURRENT OPINION IN BIOTECHNOLOGY
- Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-DOTA-ZIGF1R:4551
- (2011) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with 18F-Labeled Affibody Molecule ZHER2:2395 in a Mouse Model for Ovarian Cancer
- (2011) S. Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 Affibody
- (2011) Jennie Malmberg et al. NUCLEAR MEDICINE AND BIOLOGY
- Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
- (2011) J. T. Garrett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Radionuclide Molecular Imaging Using Affibody Molecules
- (2010) Sara Ahlgren et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels
- (2010) Vladimir Tolmachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
- (2010) E. Vegt et al. JOURNAL OF NUCLEAR MEDICINE
- Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls
- (2010) Vladimir Tolmachev et al. LANCET ONCOLOGY
- Management of breast cancer with targeted agents: importance of heterogenicity
- (2010) Serena Di Cosimo et al. Nature Reviews Clinical Oncology
- The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics
- (2010) Dhara N. Amin et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
- (2009) Edgar J. Rolleman et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount
- (2009) Vladimir Tolmachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells
- (2009) Marta Soler et al. INTERNATIONAL JOURNAL OF CANCER
- On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
- (2009) A. Orlova et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro
- (2008) M K Robinson et al. BRITISH JOURNAL OF CANCER
- Slow Internalization of Anti-HER2 Synthetic Affibody Monomer 111In-DOTA-ZHER2:342-pep2 : Implications for Development of Labeled Tracers
- (2008) Helena Wållberg et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- New Pansomatostatin Ligands and Their Chelated Versions: Affinity Profile, Agonist Activity, Internalization, and Tumor Targeting
- (2008) M. Ginj et al. CLINICAL CANCER RESEARCH
- 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals
- (2008) Melpomeni Fani et al. Contrast Media & Molecular Imaging
- 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression
- (2008) Clemens Decristoforo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Role of ErbB3 and its Binding Partners in Breast Cancer Progression and Resistance to Hormone and Tyrosine Kinase Directed Therapies
- (2008) Anne W. Hamburger JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now